Professor Bengt Jönsson
Stockholm School of Economics
Stockholm, Sweden.

Nils Wilking MD PhD
Karolinska Institute
Stockholm, Sweden

Bengt Jönsson is Professor of Health Economics at the Stockholm School of Economics, Sweden since 1990. Before that he was professor at Linköping University, Department of Health and Society, 1982-1990. He was director of the Swedish Institute for Health Economics (IHE) from 1979 to 1982, and a member of the IHE Board until 2004. He is also a member of the Karolinska University Hospital Board, and the Scientific Advisory Board, National Board of Health and Welfare, Sweden. He was also Chair of the Expert Group to the Committee on Funding and Organisation of Health Services and Medical Care in Sweden (HSU 2000), and a member of the National Social Insurance Board from 1992 to 1994, and of SBU (The Swedish Council on Technology Assessment in Health Care), Scientific Advisory Board 1988-2004.

Professor Jönsson is a member of the editorial boards of several journals, including the Journal of Health Economics, European Journal of Health Economics, Research in Health Care Financial Management, and PharmacoEconomics. He has also been a temporary adviser to the WHO and a consultant to OECD and UNIDO. Professor Jönsson's extensive publications in the field of health economics include over 200 papers, reports, and book chapters. Presently he is past president of iHEA, the international Health Economists Association.

Dr. Wilking is Associate professor at the Karolinska Institute, Stockholm, Sweden, since 1987. Between 1992-1998 Dr. Wilking was Head of the Breast, GI and Melanoma Unit at Radiumhemmet, Karolinska Hospital, Stockholm, Sweden. In 1998-2001 he was Senior Clinical Research Physician at Eli Lilly, in 2001-2002 Medical Director Oncology Scandinavia, Bristol-Myers Squibb (BMS) and in 2002-2003 Therapeutic Area Head, Oncology for BMS Europe. Since 2003 Dr. Wilking works as independent researcher for i3 Innovus, Karolinska Institutet, Stockholm County and others in parallel with his work as practicing physician. Dr. Wilking earned a PhD in Medicine from the Karolinska Institute in 1982, with focus on anti-oestrogens and breast cancer.